Leading With Excellence
IntegriChain has the deepest set of drug commercialization experts in the industry. No other commercialization partner provides the depth of policy, pricing, and reimbursement insights, pulse on regulatory changes and reforms, as well as best-in-class strategy development across all aspects of drug commercialization.
Whether you’re launching your first drug or managing a portfolio of hundreds, IntegriChain’s pharma consulting services helps you build net revenue-efficient and connected strategies for access, affordability and distribution.
Why IntegriChain is a trusted advisor on healthcare strategy, process and technology
Regulatory & Compliance
IntegriChain experts help biopharmaceutical companies craft and execute strategies to optimize their government pricing (GP), contracting, and gross-to-net (GTN). With deep experience in a wide range of regulatory services, our experts provide guidance through complex topics including Bona Fide Service Fee and Fair Market Value analysis, FSS contracting, State Price Transparency reporting, and IRA and MFP planning. Our experts conduct regular analyses to ensure your business remains compliant and scalable with quality processes in place for the future.
Finance & GTN Optimization
Biopharmaceutical manufacturers face mounting pressure to forecast and optimize net revenue accurately amid an increasingly complex regulatory and contracting environment. IntegriChain's Consulting and Advisory team brings deep, cross-functional expertise spanning all commercial functions, therapeutic categories, and drug archetypes. Backed by ICyte data from over 550 brands, our consultants are uniquely positioned to address gross-to-net strategy, resolve accrual management challenges, develop tailored forecasting models, and conduct GTN process and profitability assessments.
Policy, Pricing & Reimbursement
Navigating the regulatory landscape across HHS, CMS, OIG, DEA, and state agencies requires constant vigilance and specialized expertise. IntegriChain's team of experts monitors regulatory developments in real time, helping manufacturers anticipate and respond to the pricing implications of the Inflation Reduction Act, evolving CMS guidance, and broader industry changes. Working in close partnership with leading legal and accounting firms, we deliver timely, actionable guidance that keeps manufacturers ahead of compliance obligations and strategic inflection points.
Market Access & Payer Strategy
Our Consulting and Advisory teams bring decades of experience and expertise in understanding payer markets and how payer access varies across therapeutic categories as well as pharmacy and medical benefit products. This provides the foundation to help set and put into practice archetype-specific payer strategies that help customers achieve both patient access and net-revenue goals, including payer research, value and access assessments, pre- and post-deal analytics, and payer economic modeling.
Product & Launch Strategy
IntegriChain biopharmaceutical consultants bring a cross-functional approach to commercialization, considering the uniqueness of therapeutic areas, drug classes, patient bases, and pricing and reimbursement scenarios. This enables us to create highly tailored strategies that meet patient access and net revenue goals, supporting manufacturers from strategic planning 12 to 36 months before launch.
Provider & Pharmacy
Designing the right pharmacy and provider strategy requires a precise understanding of how channel dynamics, reimbursement mechanics, and patient support needs intersect for each product. IntegriChain brings deep expertise across all therapeutic areas and drug archetypes, helping manufacturers develop strategies that enable pharmacies and providers to efficiently deliver patient access. Our work spans SP selection and contracting, provider and site of care strategy, GPO contracting, and J-Code and HCPCS establishment.
Patient Access & Affordability
Challenges across the patient journey, from benefit verification to affordability barriers, result in significant lost prescription volume that manufacturers cannot afford to ignore. IntegriChain helps manufacturers design and optimize the full suite of patient access and affordability programs, including copay assistance, bridge therapies, and financial support tools, to drive initiation, adherence, and pull-through. Our services include patient support strategy, patient affordability programs, access and affordability vendor selection, and patient journey mapping
Data & Technology
Successful commercialization depends on accurate, timely insights around patient, provider, payer, distribution, pharmacy, and financial performance. IntegriChain is powered by the data and technology of the ICyte Platform, delivering tailored data strategies, technology assessments, vendor selection and implementation support, actionable analytics, and end-to-end operational support.
Distribution & Supply Chain
Selecting and structuring the right distribution model is one of the most consequential decisions in drug commercialization, with direct implications for patient access, channel costs, and GTN performance. IntegriChain consultants bring a proven track record across all distribution models and therapeutic categories, working alongside manufacturers to design optimal channel strategies and negotiate favorable agreements with third party logistics providers and distribution partners. Our services span distribution strategy, direct distribution, 3PL strategy and implementation, and network design and selection